⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL1197034 | 0.84 | — | — | |
| SCHEMBL30445495 | 0.79 | CA2 (0.37) | — | |
| SCHEMBL1534459 | 0.79 | CA2 (0.37) | — | |
| SCHEMBL6045116 | 0.79 | — | — | |
| SCHEMBL31694358 | 0.79 | CA2 (0.37) | — | |
| SCHEMBL354725 | 0.79 | CA2 (0.37) | — | |
| SCHEMBL31694328 | 0.79 | CA2 (0.37) | — | |
| SCHEMBL525968 | 0.79 | CA2 (0.37) | — | |
| SCHEMBL1818509 | 0.77 | — | — | |
| SCHEMBL31753673 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 672 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350315-A | 2- (1H-indole-2-yl) -1,3, 4-oxadiazole derivatives, and preparation method and application thereof | 南开大学 | 2025-01-24 | — | — | CN | claimed |
| CN-118812331-A | Process for preparing fluoroethers | 宁德时代新能源科技股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-114835765-B | Synthesis process of 2' -O- (2-methoxyethyl) guanosine | 奥锐特药业(天津)有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114835765-A | 2 a , Synthesis process of (E) -O- (2-methoxyethyl) guanosine | 奥锐特药业(天津)有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-112473396-B | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2022-06-24 | — | — | CN | claimed |
| CN-110894189-B | Preparation method of erlotinib hydrochloride | 山东罗欣药业集团股份有限公司 | 2021-07-06 | — | — | CN | claimed |
| CN-112473396-A | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2021-03-12 | — | — | CN | claimed |
| CN-110894189-A | Preparation method of erlotinib hydrochloride | 山东罗欣药业集团股份有限公司 | 2020-03-20 | — | — | CN | claimed |
| WO-2011115817-A1 | METHODS OF PREPARING 2'-O-SUBSTITUTED PURINE NUCLEOSIDES | ISIS PHARMACEUTICALS, INC. (US) | 2011-09-22 | — | — | WO | claimed |
| US-20260146049-A1 | SPIROCYCLIC ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2026-05-28 | — | — | US | disclosed |
| EP-4746963-A1 | MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | RECURSION PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| WO-2026103873-A1 | HETEROCYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF | 杭州百新生物医药科技有限公司 | 2026-05-21 | — | — | WO | disclosed |
| EP-4029868-B1 | MCL-1 INHIBITORS | GILEAD SCIENCES INC (US) | 2026-05-20 | — | — | EP | disclosed |
| US-4789665-A | ANTICARCINOGENIC AGENTS; DAUNORUBICIN DERIVATIVES | LABORATOIRES HOECHST S. A. (FR) | 1988-12-06 | — | — | US | disclosed |
| US-4357280-A | Use of tertiary phosphines in photographic silver dye bleach materials | CIBA-GEIGY AG (CH) | 1982-11-02 | — | — | US | disclosed |
| US-4138256-A | Method of processing photographic silver dye bleach materials | CIBA-GEIGY AG (CH) | 1979-02-06 | — | — | US | disclosed |
| US-3983015-A | Electrochemical fluorination using excess current | PHILLIPS PETROLEUM COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3981783-A | Electrochemical fluorination process utilizing excess current and hydrogen addition | PHILLIPS PETROLEUM COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
| US-3970728-A | INSECTICIDE, MITICIDE, NEMATOCIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-20 | — | — | US | disclosed |